Delivery of tumor antigens to dendritic cells using biodegradable microspheres
- PMID: 15585911
- DOI: 10.1385/1-59259-862-5:035
Delivery of tumor antigens to dendritic cells using biodegradable microspheres
Abstract
Poly(D,L-lactide-co-glycolide) (PLGA) polymers have been used for the production of biodegradable medical sutures and for controlled drug release for decades. Useful characteristics such as in vivo biodegradability, an adjustable release profile, and the very high encapsulation capacity have stimulated immunologists to explore PLGA microspheres (MS) as antigen delivery systems for vaccination for more than 15 yr. In previous studies aiming at the development of "single-dose" vaccines, direct immunization with PLGA MS containing various antigens induced strong and sustained immune responses. We have observed that human immature monocyte-derived dendritic cells (MoDC) prepared for clinical application are able to internalize high numbers of MS without negative effects on their pivotal properties. Furthermore, PLGA-MS-incorporated antigens are effectively processed for presentation on major histocompatibility complex (MHC) class I and MHC class II molecules by dendritic cells (DCs) in vitro and induced strong cytotoxic T-lymphocyte (CTL) responses in vivo. Taken together, PLGA MS is a promising delivery vehicle for the improvement of current DC-based tumor vaccine protocols.
Similar articles
-
Encapsulation of peptides in biodegradable microspheres prolongs their MHC class-I presentation by dendritic cells and macrophages in vitro.Vaccine. 2003 Mar 7;21(11-12):1250-5. doi: 10.1016/s0264-410x(02)00521-2. Vaccine. 2003. PMID: 12559806
-
Phenotype and functional analysis of human monocyte-derived dendritic cells loaded with biodegradable poly(lactide-co-glycolide) microspheres for immunotherapy.J Immunol Methods. 2004 Apr;287(1-2):109-24. doi: 10.1016/j.jim.2004.01.010. J Immunol Methods. 2004. PMID: 15099760
-
Harnessing Dendritic Cells for Poly (D,L-lactide-co-glycolide) Microspheres (PLGA MS)-Mediated Anti-tumor Therapy.Front Immunol. 2019 Apr 5;10:707. doi: 10.3389/fimmu.2019.00707. eCollection 2019. Front Immunol. 2019. PMID: 31024545 Free PMC article. Review.
-
Encapsulation of proteins and peptides into biodegradable poly(D,L-lactide-co-glycolide) microspheres prolongs and enhances antigen presentation by human dendritic cells.Vaccine. 2006 Mar 10;24(11):1847-57. doi: 10.1016/j.vaccine.2005.10.032. Epub 2005 Oct 25. Vaccine. 2006. PMID: 16288821
-
PLGA microspheres for improved antigen delivery to dendritic cells as cellular vaccines.Adv Drug Deliv Rev. 2005 Jan 10;57(3):475-82. doi: 10.1016/j.addr.2004.09.007. Adv Drug Deliv Rev. 2005. PMID: 15560953 Review.
Cited by
-
Poly(lactic acid)-poly(ethylene glycol) nanoparticles provide sustained delivery of a Chlamydia trachomatis recombinant MOMP peptide and potentiate systemic adaptive immune responses in mice.Nanomedicine. 2014 Aug;10(6):1311-21. doi: 10.1016/j.nano.2014.02.009. Epub 2014 Mar 4. Nanomedicine. 2014. PMID: 24602605 Free PMC article.
-
Enhanced stimulation of anti-ovarian cancer CD8(+) T cells by dendritic cells loaded with nanoparticle encapsulated tumor antigen.Am J Reprod Immunol. 2011 Jun;65(6):597-609. doi: 10.1111/j.1600-0897.2010.00968.x. Epub 2011 Jan 18. Am J Reprod Immunol. 2011. PMID: 21241402 Free PMC article.
-
Multifunctional dendritic cell-targeting polymeric microparticles: engineering new vaccines for type 1 diabetes.Hum Vaccin. 2011 Jan 1;7(1):37-44. doi: 10.4161/hv.7.1.12916. Epub 2011 Jan 1. Hum Vaccin. 2011. PMID: 21157186 Free PMC article. Review. No abstract available.
-
Active self-healing encapsulation of vaccine antigens in PLGA microspheres.J Control Release. 2013 Jan 10;165(1):62-74. doi: 10.1016/j.jconrel.2012.10.012. Epub 2012 Oct 24. J Control Release. 2013. PMID: 23103983 Free PMC article.
-
Efficient ex vivo induction of T cells with potent anti-tumor activity by protein antigen encapsulated in nanoparticles.Cancer Immunol Immunother. 2013 Jul;62(7):1161-73. doi: 10.1007/s00262-013-1411-0. Epub 2013 Apr 24. Cancer Immunol Immunother. 2013. PMID: 23613147 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Research Materials